Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,995 | 83 | 88.6% |
| Education | $255.41 | 10 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $353.47 | 13 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $302.86 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $292.20 | 11 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $230.80 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $230.09 | 11 | $0 (2024) |
| Vifor Pharma, Inc. | $193.52 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $145.21 | 6 | $0 (2022) |
| Travere Therapeutics, Inc. | $93.12 | 4 | $0 (2024) |
| Ardelyx, Inc. | $71.35 | 3 | $0 (2024) |
| Relypsa, Inc. | $66.72 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $567.36 | 22 | Otsuka America Pharmaceutical, Inc. ($111.31) |
| 2023 | $699.84 | 29 | Otsuka America Pharmaceutical, Inc. ($217.34) |
| 2022 | $410.10 | 16 | Bayer HealthCare Pharmaceuticals Inc. ($143.51) |
| 2021 | $383.72 | 17 | AstraZeneca Pharmaceuticals LP ($124.12) |
| 2020 | $188.91 | 9 | Relypsa, Inc. ($66.72) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: VIROLOGY | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/13/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.21 | General |
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: NEPHROLOGY | ||||||
| 07/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $23.08 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Rare Disease | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Cardio-renal | ||||||
| 05/21/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/07/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $31.92 | General |
| Category: NEPHROLOGY | ||||||
| 05/02/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 05/01/2024 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $44.77 | General |
| 04/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: NEPHROLOGY | ||||||
| 04/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: NEPHROLOGY | ||||||
| 02/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $31.14 | General |
| Category: NEPHROLOGY | ||||||
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: NEPHROLOGY | ||||||
| 01/16/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Cardio-renal | ||||||
| 12/19/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Hyperkalemia | ||||||
| 11/22/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 346 | 832 | $394,064 | $123,228 |
| 2022 | 10 | 419 | 1,123 | $470,488 | $150,267 |
| 2021 | 7 | 429 | 1,103 | $394,588 | $128,752 |
| 2020 | 6 | 163 | 378 | $116,117 | $38,156 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 134 | $136,805 | $42,717 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 106 | 314 | $70,584 | $22,409 | 31.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2023 | 14 | 51 | $52,249 | $15,370 | 29.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 125 | $41,785 | $13,579 | 32.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 82 | $42,174 | $12,658 | 30.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 33 | $28,004 | $8,773 | 31.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 25 | $9,678 | $2,990 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 24 | $6,816 | $2,704 | 39.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 44 | $5,969 | $2,028 | 34.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 19 | 131 | $137,999 | $43,527 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 124 | 492 | $103,064 | $33,803 | 32.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2022 | 12 | 51 | $53,725 | $16,587 | 30.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 55 | $48,140 | $15,282 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 143 | $42,969 | $13,711 | 31.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 65 | $37,978 | $11,743 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 37 | $14,870 | $4,680 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 28 | $8,080 | $3,373 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 22 | $9,541 | $3,232 | 33.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 45 | 85 | $9,846 | $3,159 | 32.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 14 | $4,275 | $1,170 | 27.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 144 | 528 | $111,392 | $36,612 | 32.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 177 | $53,661 | $17,811 | 33.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2021 | 12 | 52 | $53,924 | $17,607 | 32.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 12 | 60 | $52,491 | $16,797 | 32.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 83 | $48,910 | $15,603 | 31.9% |
About Dr. Muhammad Khan, MD
Dr. Muhammad Khan, MD is a Nephrology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1699200634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Khan, MD has received a total of $2,250 in payments from pharmaceutical and medical device companies, with $567.36 received in 2024. These payments were reported across 93 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,995).
As a Medicare-enrolled provider, Khan has provided services to 1,357 Medicare beneficiaries, totaling 3,436 services with total Medicare billing of $440,403. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Brooklyn, NY
- Active Since 04/27/2017
- Last Updated 09/24/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699200634
Products in Payments
- JYNARQUE (Drug) $353.47
- LUPKYNIS (Drug) $302.86
- Kerendia (Drug) $292.20
- Veltassa (Drug) $260.24
- RAYALDEE (Drug) $230.80
- LOKELMA (Drug) $230.09
- BENLYSTA (Biological) $145.21
- IBSRELA (Drug) $71.35
- ULTOMIRIS (Biological) $32.20
- WATCHMAN FLX (Device) $29.51
- INGREZZA (Drug) $24.87
- Vafseo (Drug) $24.61
- Parsabiv (Drug) $23.60
- MAVYRET (Drug) $22.96
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $21.86
- Velphoro (Drug) $20.07
- STRENSIQ (Biological) $17.64
- LifeVest (Device) $8.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Brooklyn
Gregg Miller, Md, MD
Nephrology — Payments: $57,485
Alla Maslova
Nephrology — Payments: $18,516
Li Yang, Md, MD
Nephrology — Payments: $17,726
Dr. Louis Carrera, Md, MD
Nephrology — Payments: $17,135
Dr. Mariana Markell, M.d, M.D
Nephrology — Payments: $15,506
Dr. Alan Nissenbaum, Md, MD
Nephrology — Payments: $15,228